Transcription regulatory factor and its mutant and its application in the preparation of vitamin b12

A technology for transcriptional regulators, vitamins, applied in applications, microorganism-based methods, microorganisms, etc., can solve problems such as affecting vitamin B production

Active Publication Date: 2020-05-12
TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in the production of vitamin B 12 Which transcription regulator in bacterial species affects vitamin B 12 The output has not been reported yet

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Transcription regulatory factor and its mutant and its application in the preparation of vitamin b12
  • Transcription regulatory factor and its mutant and its application in the preparation of vitamin b12
  • Transcription regulatory factor and its mutant and its application in the preparation of vitamin b12

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0035] (2) Preparation of standard products

[0036] Configuration gradient vitamin B 12Standards (20 mg / L, 50 mg / L, 100 mg / L, 150 mg / L).

[0037] (3) HPLC detection conditions

[0038] C18-250A column (Agilent, 4.6 mmid 9 × 250 mm, 5 µm). The mobile phase was 70% organic phase (acetonitrile) and 30% inorganic phase (sodium acetate aqueous solution), the absorption wavelength was 361 nm, the column temperature was 35 °C, the flow rate was 0.8 mL / min, and the injection volume was 20 µL.

[0039] (4) Vitamin B 12 Drawing of standard curve

[0040] Standards with different concentrations were detected by HPLC according to the above conditions, and the peak areas A-VB were drawn 12 Concentration standard curve. Taking the measured peak area A as the ordinate, vitamin B 12 The mass concentration C (mg / L) is recorded as the abscissa, and vitamin B is drawn 12 standard curve line. See Image 6 , get the regression equation y=19.846x-80.857, R 2 =0.999, the absorbance has a...

Embodiment 1

[0041] Example 1: Determination of mutagenesis time by atmospheric room temperature plasma (ARTP), construction of mutant library and acquisition of high-yielding strains

[0042] (1) Determination of lethality

[0043] In order to obtain a relatively broad mutant library, we carried out atmospheric room temperature plasma (ARTP) mutagenesis on the chassis cell Sinorhizobium meliloti CGMCC NO.9638. First, the lethality of CGMCCNO.9638 was determined under plasma mutagenesis conditions. CGMCC NO.9638 cells (OD 600 =1) Rinse twice with 0.85% NaCl solution, then dilute to 10 with 0.85% NaCl solution 8 cells / mL suspension. Take 10uL of the suspension and spread it evenly on the iron sheet, and carry out ARTP mutagenesis. Three replicates were plated for each time point. After mutagenesis, place the iron sheet with cells in 1 mL of sterile water and vortex to wash the cells, and dilute the cell suspension 10 times to 10 -3 , Take 100 μL of the diluted cell suspension and spre...

Embodiment 2

[0053] Example 2: Comparative genome analysis of mutant strains and starting strains

[0054] The strain SM* and the starting strain CGMCC NO.9638 were sent to Jinweizhi Biotechnology Co., Ltd. for whole genome sequencing. By comparing the whole genome sequences of the two strains, it was found that 5 transcriptional regulators had point mutations, as shown in Table 2. In order to verify the effect of the mutation site on vitamin B 12 For the impact on yield, we overexpressed the mutated transcriptional regulator gene in the starting strain CGMCC NO.9638.

[0055]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a kind of transcription regulation factors TR1 and TR2, their mutants, and their production of vitamin B 12 in the application. Genetically engineered bacteria overexpressing the transcriptional regulators TR1 and TR2, or their mutant genes, in S. meliloti to produce vitamin B 12 The ability has been greatly improved, and it has great application and promotion value.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to transcription regulators TR1 and TR2, their mutants, and their use in the preparation of vitamin B 12 in the application. Background technique [0002] Vitamin B 12 (VB 12 ) is widely used in the pharmaceutical and food industries. It is also called cobalamin, which belongs to corrin compounds. It is the only vitamin compound containing metal elements and is the latest macromolecular organic compound discovered by B vitamins. Depending on the type of ligand (R group) above the corrin ring, vitamin B 12 Can be divided into: hydroxycobalamin, deoxyadenosylcobalamin and methylcobalamin. Vitamin B 12 Participated in a large number of biochemical reactions including DNA synthesis and regulation, fatty acid synthesis, amino acid metabolism and capacity generation. [0003] due to vitamin B 12 The molecular structure is complex, and chemical synthesis requires a lot of m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/31C07K14/195C12N15/74C12P19/42C12N1/20C12N13/00C12R1/41
CPCC07K14/195C12P19/42
Inventor 张大伟董会娜
Owner TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap